Showing 21-30 of 1572 results for "".
Beyond the Embryonic Stem Cell Debate
https://reachmd.com/programs/clinicians-roundtable/beyond-the-embryonic-stem-cell-debate/4314/Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief exeMisconceptions of Embryonic Stem Cell Potential
https://reachmd.com/programs/clinicians-roundtable/misconceptions-of-embryonic-stem-cell-potential/965/In this segment, Dr. James Sherley explains relationship between stem cells and human organs. He proposes that the future of embryonic stem cells are mis-represented and will not ever be able to deliver upon the many promises made.The Stem Cell Research Debate
https://reachmd.com/programs/clinicians-roundtable/the-stem-cell-research-debate/967/Dr. James Sherley, a stem cell heretic, discusses his stem cell views and proposes that many other researchers in his field share his strong views but do not always speak out because of their desire to get tenure and or be published. He also explains his side of the story regarding his tenure at MIAdult Stem Cells, Cloning, Gene Therapy
https://reachmd.com/programs/clinicians-roundtable/adult-stem-cells-cloning-gene-therapy/966/In this segment Dr. Sherley speaks about many stem cell related topics including the relationship between stem cells and cloning, gene therapy and how adult stem cells work.Issues in Funding Pluripotent Stem Cell Research
https://reachmd.com/programs/clinicians-roundtable/issues-in-funding-pluripotent-stem-cell-research/4632/Expanded guidelines for stem cell research have favored federal financing for embryonic stem cell development. But some researchers in the field are looking beyond embryonic stem cells. Ken Aldrich, chief executive officer and co-founder of International Stem Cell Corporation, tells host Bruce JapseMaking Progress With Stem Cell Treatments
https://reachmd.com/programs/clinicians-roundtable/making-progress-with-stem-cell-treatments/2489/A journal Nature report that scientists cloned an embryo of a monkey and harvested its stem cells have grabbed headlines, but just how much progress are we really making in stem cell treatments? Dr. Douglas Losordo, head of the program in Cardiovascular Medicine at Northwestern University tells theWhat triggers stem cells to differentiate?
https://reachmd.com/programs/clinicians-roundtable/what-triggers-stem-cells-to-differentiate/2252/John A. Kessler MD, Davee Professor of Stem Cell Biology, Chairman, Davee Department of Neurology, Northwestern University Medical School, is one of the world’s leaders in stem cell research to repair central and peripheral nerve damage. He joins us to talk about how growth factors promote neuronalThe Root of Tooth Regeneration and Stem Cells
https://reachmd.com/programs/clinicians-roundtable/the-root-of-tooth-regeneration-and-stem-cells/2895/What are the mechanisms behind animal tooth regeneration, and what can tooth stem cell research tell us? Your host, Dr. Bruce Bloom and Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco discuss stem cell research and the potential clinical apThe Promise of Stem Cells Reaching Patients
https://reachmd.com/programs/clinicians-roundtable/the-promise-of-stem-cells-reaching-patients/2971/The promise of stem cell research, once deemed a scientists' dream, has turned the corner into real marketed products and looks to soon be a multi-billion-dollar industry. Randal Mills, the chief executive officer of Osiris Therapeutics tells the Chicago Tribune's Bruce Japsen about stem cell producReprogamming Skin Cells to Act Like Stem Cells
https://reachmd.com/programs/clinicians-roundtable/reprogamming-skin-cells-to-act-like-stem-cells/2588/Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, h